loading
前日終値:
$26.05
開ける:
$26.13
24時間の取引高:
427.42K
Relative Volume:
0.27
時価総額:
$1.25B
収益:
-
当期純損益:
$-97.22M
株価収益率:
-12.74
EPS:
-2.19
ネットキャッシュフロー:
$-82.44M
1週間 パフォーマンス:
+5.74%
1か月 パフォーマンス:
-4.29%
6か月 パフォーマンス:
+24.11%
1年 パフォーマンス:
+23.89%
1日の値動き範囲:
Value
$26.03
$27.80
1週間の範囲:
Value
$25.46
$29.49
52週間の値動き範囲:
Value
$8.79
$42.20

Cassava Sciences Inc Stock (SAVA) Company Profile

Name
名前
Cassava Sciences Inc
Name
セクター
Healthcare (1195)
Name
電話
512-501-2444
Name
住所
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
Name
職員
29
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
SAVA's Discussions on Twitter

SAVA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
SAVA 27.80 1.25B 0 -97.22M -82.44M -2.19
VRTX 447.73 115.74B 10.63B -479.80M -1.35B 13.33
REGN 744.52 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 589.19 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.27 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.47 24.49B 3.30B -501.07M 1.03B 11.54

Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-11-16 ダウングレード B. Riley Securities Buy → Neutral
2021-07-15 ダウングレード Cantor Fitzgerald Overweight → Neutral
2021-07-07 繰り返されました Maxim Group Buy
2021-04-27 開始されました B. Riley Securities Buy
2021-02-16 繰り返されました H.C. Wainwright Buy
2020-10-23 開始されました Cantor Fitzgerald Overweight
2020-09-23 アップグレード H.C. Wainwright Neutral → Buy
2020-05-18 ダウングレード H.C. Wainwright Buy → Neutral
2020-05-15 ダウングレード Maxim Group Buy → Hold
2020-01-10 繰り返されました Maxim Group Buy
すべてを表示

Cassava Sciences Inc (SAVA) 最新ニュース

pulisher
Nov 19, 2024

Is Cassava Sciences (SAVA) Outperforming Other Medical Stocks This Year? - MSN

Nov 19, 2024
pulisher
Nov 18, 2024

Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer - citybiz

Nov 18, 2024
pulisher
Nov 18, 2024

Cassava Sciences, Inc. Appoints Freda Nassif as Chief Commercial Officer - Marketscreener.com

Nov 18, 2024
pulisher
Nov 15, 2024

Cassava Sciences stock up on Alzheimer’s update (SAVA:NASDAQ) - Seeking Alpha

Nov 15, 2024
pulisher
Nov 13, 2024

What Makes Cassava Sciences (SAVA) a New Buy Stock - MSN

Nov 13, 2024
pulisher
Nov 12, 2024

A High-potential Bull Put Strategy on Cassava Sciences - MSN

Nov 12, 2024
pulisher
Nov 12, 2024

A High-Potential Bull Put Strategy On Cassava Sciences - Barchart

Nov 12, 2024
pulisher
Nov 12, 2024

Cassava Sciences Inc (SAVA-Q) QuotePress Release - The Globe and Mail

Nov 12, 2024
pulisher
Nov 11, 2024

Anavex, Cassava Sciences, Panax Ginseng, And Long-Term Treatment Of Alzheimer's Disease - Seeking Alpha

Nov 11, 2024
pulisher
Nov 10, 2024

How To Trade (SAVA) - Stock Traders Daily

Nov 10, 2024
pulisher
Nov 09, 2024

Cassava Sciences, Inc. (NASDAQ:SAVA) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024
pulisher
Nov 09, 2024

Cassava Sciences (NASDAQ:SAVA) Issues Quarterly Earnings Results - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

Cassava Sciences (NASDAQ:SAVA) Given "Buy" Rating at HC Wainwright - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

Cassava Sciences Q3 2024 Earnings Preview - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla? - Benzinga

Nov 08, 2024
pulisher
Nov 08, 2024

Another U.S. biotech based on Chinese science - STAT

Nov 08, 2024
pulisher
Nov 08, 2024

Cassava Sciences: With Almost Half The Float Shorted, Results Could Be Interesting - Seeking Alpha

Nov 08, 2024
pulisher
Nov 08, 2024

Cassava Sciences nears Alzheimer's drug trial results By Investing.com - Investing.com Canada

Nov 08, 2024
pulisher
Nov 08, 2024

Cassava Sciences’ Q3 2024: Financials and Alzheimer’s Trials Progress - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Cassava Sciences: Pivotal Alzheimer’s Data May Push Stock Toward Book Value (SAVA) - Seeking Alpha

Nov 07, 2024
pulisher
Nov 07, 2024

Cassava Q3 Earnings Review: It Feels Like The End May Be Nigh (NASDAQ:SAVA) - Seeking Alpha

Nov 07, 2024
pulisher
Nov 07, 2024

Looking At Cassava Sciences's Recent Unusual Options Activity - Benzinga

Nov 07, 2024
pulisher
Nov 07, 2024

Cassava Sciences nears Alzheimer's drug trial results - Investing.com India

Nov 07, 2024
pulisher
Nov 07, 2024

Cassava Sciences stock in focus after earnings (SAVA:NASDAQ) - Seeking Alpha

Nov 07, 2024
pulisher
Nov 07, 2024

Cassava Sciences Reports Q3 2024 Financial and Operating Results - The Manila Times

Nov 07, 2024
pulisher
Nov 06, 2024

Cassava Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024
pulisher
Nov 05, 2024

Cassava Sciences (NASDAQ:SAVA) Trading Down 5.8%Should You Sell? - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Unpacking the Latest Options Trading Trends in Cassava Sciences - Benzinga

Nov 05, 2024
pulisher
Nov 04, 2024

Analysts Believe Cassava Sciences Now Has 300% Upside From Here - MSN

Nov 04, 2024
pulisher
Nov 01, 2024

Cassava Sciences (SAVA) Scheduled to Post Earnings on Thursday - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024 - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

International Assets Investment Management LLC Makes New Investment in Cassava Sciences, Inc. (NASDAQ:SAVA) - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Institutions along with individual investors who hold considerable shares inCassava Sciences, Inc. (NASDAQ:SAVA) come under pressure; lose 6.7% of holdings value - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Long Term Trading Analysis for (SAVA) - Stock Traders Daily

Oct 30, 2024
pulisher
Oct 26, 2024

HC Wainwright & Co. Upgrades Cassava Sciences (SAVA) - MSN

Oct 26, 2024
pulisher
Oct 24, 2024

Cassava Sciences Options Trading: A Deep Dive into Market Sentiment - Benzinga

Oct 24, 2024
pulisher
Oct 21, 2024

Institutions profited after Cassava Sciences, Inc.'s (NASDAQ:SAVA) market cap rose US$72m last week but individual investors profited the most - Simply Wall St

Oct 21, 2024
pulisher
Oct 19, 2024

(SAVA) Proactive Strategies - Stock Traders Daily

Oct 19, 2024
pulisher
Oct 17, 2024

Cassava Sciences, Inc. (SAVA): Jim Cramer Says Eli Lilly Has The Edge - Insider Monkey

Oct 17, 2024
pulisher
Oct 14, 2024

Cassava Sciences (NASDAQ:SAVA) Trading 5.1% HigherWhat's Next? - MarketBeat

Oct 14, 2024
pulisher
Oct 10, 2024

HC Wainwright Comments on Cassava Sciences, Inc.'s FY2025 Earnings (NASDAQ:SAVA) - MarketBeat

Oct 10, 2024

Cassava Sciences Inc (SAVA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Cassava Sciences Inc (SAVA) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Barry Richard
Director
Apr 23 '24
Option Exercise
22.00
176,085
3,873,870
469,562
Kupiec James William
Chief Medical Officer
Apr 18 '24
Option Exercise
22.00
1,500
33,000
4,000
Schoen Eric
Chief Financial Officer
Apr 17 '24
Option Exercise
22.00
1,500
33,000
21,300
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):